Us Congress House Bill HR371

Us Congress 2025-2026 Regular Session

• Introduced: 5/1/25
• Refer: 5/1/25

Caption

Expressing support for the designation of May 2025 as "National Brain Tumor Awareness Month".

Impact

The resolution is intended to encourage collaboration in brain tumor research and to elevate public consciousness surrounding the realities of living with brain tumors. By designating a specific month to focus on this cause, it aims to promote outreach and advocacy efforts nationwide. This recognition is particularly significant given the alarming statistics regarding brain tumors, including their status as the leading cause of cancer death among children and young adults. Advocates hope that the designated month will inspire both governmental and non-governmental efforts to improve research and treatment outcomes.

Summary

House Resolution 371 expresses support for the designation of May 2025 as 'National Brain Tumor Awareness Month.' This resolution highlights the need for increased public awareness of brain tumors and advocates for better treatment options for individuals diagnosed with brain tumors. The resolution aims to honor those affected by brain tumors, including patients, their families, and caregivers, and recognizes the significant challenges posed by brain tumors, including the complexity of treatment and the need for ongoing research.

Contention

While there is broad support for increased awareness of brain tumors, the resolution's lack of specific legislative actions or funding directives has raised some questions among public health advocates. Some may argue that simply designating a month without accompanying measures may not lead to substantive changes in research funding or healthcare practices. The conversation around the resolution invites discussions on the effectiveness of awareness campaigns, especially when resources for research and treatment remain limited. Furthermore, this initiative highlights the disparities in funding and research efforts related to brain tumors compared to other cancers, prompting a call for a more balanced approach to cancer treatment funding.